Han Wu
Impact in
- Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver physiology and pathology
- Cancer Research top 5%
- Cancer, Lipids, and Metabolism
- Cancer, Hypoxia, and Metabolism
Papers in
- Hepatology 32
- Hepatocellular Carcinoma Treatment and Prognosis 28
-
- Cancer, Lipids, and Metabolism 12
- Cancer, Hypoxia, and Metabolism 8
Han Wu
86 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 126
- Hepatology 709
- Cancer Research 625
- Oncology 527
- Immunology 342
- Epidemiology 533
Countries citing papers authored by Han Wu
This map shows the geographic impact of Han Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Han Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Han Wu more than expected).
Fields of papers citing papers by Han Wu
This network shows the impact of papers produced by Han Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Han Wu. The network helps show where Han Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Han Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 3 | |
| 3 | 2024 | 10 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 13 | |
| 6 | 2023 | 3 | |
| 7 | 2022 | 9 | |
| 8 | 2021 | 1 | |
| 9 | 2021 | 1 | |
| 10 | 2020 | 10 | |
| 11 | 2019 | 35 | |
| 12 | 2019 | 55 | |
| 13 | 2019 | 57 | |
| 14 | 2019 | 9 | |
| 15 | 2018 | 117 | |
| 16 | 2018 | 36 | |
| 17 | 2018 | 20 | |
| 18 | 2016 | 70 | |
| 19 | 2014 | 24 | |
| 20 | 2013 | 144 |
About Han Wu
Han Wu is a scholar working on Hepatology, Cancer Research, Epidemiology, Immunology and Oncology, having authored 92 papers that have together received 2.5k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (28 papers), Liver Disease Diagnosis and Treatment (19 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (12 papers), Hepatitis B Virus Studies (12 papers), Cancer, Lipids, and Metabolism (12 papers), Nanoplatforms for cancer theranostics (11 papers), Cancer, Hypoxia, and Metabolism (8 papers) and RNA modifications and cancer (5 papers). The work is most often cited by research in Hepatology (709 citations), Cancer Research (625 citations), Oncology (527 citations), Immunology (342 citations) and Epidemiology (533 citations). Han Wu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Tian Yang, Mengchao Wu, Yihua Wu, Feng Shen, Ming-Da Wang, Hao Xing, Wan Yee Lau, Dajing Xia, Jiaxing Wang and Jia Fan. Their work appears in journals such as HPB, Journal of Gastrointestinal Surgery, Annals of Surgical Oncology, Surgery and Small.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.